Close

Intercept Pharmaceuticals (ICPT) PT Lowered to $200 at Oppenheimer, Keeps 'Outperform'

Go back to Intercept Pharmaceuticals (ICPT) PT Lowered to $200 at Oppenheimer, Keeps 'Outperform'